✦ LIBER ✦

Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy

✍ Scribed by Olivier Meyer; Michel de Bandt; Jean-Marie Berthelot; Alain Cantagrel; Bernard Combe; Bruno Fautrel; René-Marc Flipo; Frédéric Lioté; Jean-Francis Maillefert; Alain Saraux; Daniel Wendling; Francis Guillemin; Xavier Le Loët

Book ID: 113684178
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 205 KB
Volume: 74
Category: Article
ISSN: 1297-319X
DOI: 10.1016/j.jbspin.2006.05.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Choice of second-line disease-modifying

Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: A decision tree for clinical practice based on rheumatologists' preferences

✍ Fautrel, Bruno ;Guillemin, Francis ;Meyer, Olivier ;de Bandt, Michel ;Berthelot, 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 1 views

Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6&#xa0;months' first-line DMARD therapy

Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy